Koji Kono

7PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 18, 2026
Prognostic Impact of Histologic Subtypes in Mismatch Repair-Deficient/Microsatellite Instability-High Colorectal Cancer: A Single-Center Retrospective Study of 1127 Stage 0-IV Patients.

|Aug 18, 2025
GALNT7 Stratifies dMMR/MSI Colorectal Cancer into Distinct Molecular Subsets Associated with Prognosis and PD-L1 Expression.

Hiroya Suzuki, Hirokazu Okayama, Shotaro Nakajima

|Aug 30, 2024
Appropriate timing for the removal of urinary catheters in gastrointestinal surgery with epidural anesthesia: a randomized controlled trial.

Teppei Miyakawa, Michitaka Honda, Hidetaka Kawamura

|Apr 22, 2024
Biomarker-oriented chemo-immunotherapy for advanced gastric cancer.

Koji Kono, Shotaro Nakajima, Kosaku Mimura

|Aug 15, 2023
Phase I/II clinical trial of nivolumab in combination with oligo-fractionated irradiation for unresectable advanced or recurrent gastric cancer.

Kosaku Mimura, Takashi Ogata, Yuya Yoshimoto

|Oct 17, 2017
PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer.

Kousaku Mimura, Jun Liang Teh, Hirokazu Okayama

Pageof 2

Frequent Collaborators

2 joint publications

Kousaku Mimura

2 joint publications

Hirokazu Okayama

2 joint publications

Wataru Sakamoto

1 joint publications

Fumiaki Takahashi